BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10850302)

  • 1. Synthetic, implantable, biodegradable polymers for controlled release of radiosensitizers.
    Yuan X; Fahlman C; Tabassi K; Williams JA
    Cancer Biother Radiopharm; 1999 Jun; 14(3):177-86. PubMed ID: 10850302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma.
    Yuan X; Dillehay LE; Williams JR; Williams JA
    Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma.
    Williams JA; Dillehay LE; Tabassi K; Sipos E; Fahlman C; Brem H
    J Neurooncol; 1997 May; 32(3):181-92. PubMed ID: 9049879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
    Yuan X; Tabassi K; Williams JA
    Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic, implantable polymers for local delivery of IUdR to experimental human malignant glioma.
    Williams JA; Yuan X; Dillehay LE; Shastri VR; Brem H; Williams JR
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):631-9. PubMed ID: 9806525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEG modulated release of etanidazole from implantable PLGA/PDLA discs.
    Wang F; Lee T; Wang CH
    Biomaterials; 2002 Sep; 23(17):3555-66. PubMed ID: 12109679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitization of a mouse tumor model by sustained intra-tumoral release of etanidazole and tirapazamine using a biodegradable polymer implant device.
    Yapp DT; Lloyd DK; Zhu J; Lehnert S
    Radiother Oncol; 1999 Oct; 53(1):77-84. PubMed ID: 10624857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor radiosensitization by sustained intratumoral release of bromodeoxyuridine.
    Doiron A; Yapp DT; Olivares M; Zhu JX; Lehnert S
    Cancer Res; 1999 Aug; 59(15):3677-81. PubMed ID: 10446981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IUdR polymers for combined continuous low-dose rate and high-dose rate sensitization of experimental human malignant gliomas.
    Yuan X; Dillehay LE; Williams JR; Shastri VR; Williams JA
    Int J Cancer; 2001 Apr; 96(2):118-25. PubMed ID: 11291095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodo-2'-deoxyuridine (IUdR) and 125IUdR loaded biodegradable microspheres for controlled delivery to the brain.
    Reza MS; Whateley TL
    J Microencapsul; 1998; 15(6):789-801. PubMed ID: 9818956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain.
    Brem H; Tamargo RJ; Olivi A; Pinn M; Weingart JD; Wharam M; Epstein JI
    J Neurosurg; 1994 Feb; 80(2):283-90. PubMed ID: 8283268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors.
    Sipos EP; Tyler B; Piantadosi S; Burger PC; Brem H
    Cancer Chemother Pharmacol; 1997; 39(5):383-9. PubMed ID: 9054951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain.
    Brem H; Kader A; Epstein JI; Tamargo RJ; Domb A; Langer R; Leong KW
    Sel Cancer Ther; 1989; 5(2):55-65. PubMed ID: 2772427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain biocompatibility of a biodegradable, controlled-release polymer in rats.
    Tamargo RJ; Epstein JI; Reinhard CS; Chasin M; Brem H
    J Biomed Mater Res; 1989 Feb; 23(2):253-66. PubMed ID: 2708412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy.
    Wu MP; Tamada JA; Brem H; Langer R
    J Biomed Mater Res; 1994 Mar; 28(3):387-95. PubMed ID: 8077254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained release system for highly water-soluble radiosensitizer drug etanidazole: irradiation and degradation studies.
    Yip EY; Wang J; Wang CH
    Biomaterials; 2003 May; 24(11):1977-87. PubMed ID: 12615488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simulation of intratumoral release of Etanidazole: effects of the size of surgical opening.
    Tan WH; Lee T; Wang CH
    J Pharm Sci; 2003 Apr; 92(4):773-89. PubMed ID: 12661063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained local anesthetic release from bioerodible polymer matrices: a potential method for prolonged regional anesthesia.
    Masters DB; Berde CB; Dutta S; Turek T; Langer R
    Pharm Res; 1993 Oct; 10(10):1527-32. PubMed ID: 8272418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel: in vitro release and in vivo toxicity.
    Shikanov A; Vaisman B; Krasko MY; Nyska A; Domb AJ
    J Biomed Mater Res A; 2004 Apr; 69(1):47-54. PubMed ID: 14999750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer simulation of the delivery of etanidazole to brain tumor from PLGA wafers: comparison between linear and double burst release systems.
    Tan WH; Wang F; Lee T; Wang CH
    Biotechnol Bioeng; 2003 May; 82(3):278-88. PubMed ID: 12599254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.